PCORI funding approved for pragmatic clinical trial to compare combination versus monotherapy in children with Crohn's disease
Posted by ImproveCareNow™ on April 27, 2015
Michael D. Kappelman, MD, MPH of the University of North Carolina at Chapel Hill (read the UNC press release here) and the ImproveCareNow Network has been awarded $7.9 million in funding from the Patient Centered Outcomes Research Institute (PCORI) to conduct a five year study comparing Anti-TNF Monotherapy versus Combination Therapy with Low Dose Methotrexate in Pediatric Crohn’s Disease.
Read more